Stock Screener App

Gratuito -

Installare

7.32

0.68% -0.05

Maravai Lifesciences Holdings Inc (MRVI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MRVI Giù? Forum Previsione

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm

Why Maravai LifeSciences Holdings (MRVI) Stock Climbed After Its Latest Update - Sahm

Maravai Lifesciences stock reaches 52-week high of 8.15 USD By Investing.com - Investing.com Nigeria

Maravai Lifesciences Up Over 30%, on Pace for Largest Percent Increase in Over a Year -- Data Talk - Bitget

Maravai Lifesciences Earnings Call Highlights Margin Rebound - TipRanks

MRVI Q2 2026 Earnings: Loss Narrows Sharply as EPS Beats Estimates by 54.65%Post-Announcement Reaction - vinanet.vn

Maravai LifeSciences (MRVI) Slides 1.38% to $5.70 as Key Support Level Comes into FocusALMA Signal - vinanet.vn

Wall Street Zen Upgrades Maravai LifeSciences (NASDAQ:MRVI) to Buy - MarketBeat

Maravai Lifesciences Holdings Inc (NASDAQ: MRVI) Stock Price, News & Analysis - Kalkine

Maravai (MRVI) Q2 2026 Earnings Call Transcript - AOL.com

Maravai LifeSciences (MRVI) group reports 4.0M shares, 2.72% beneficial stake - Stock Titan

Dimensional Fund Advisors LP Boosts Holdings in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

Maravai LifeSciences (NASDAQ:MRVI) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Maravai Q2 2026 slides: margin expansion drives EBITDA guidance raise By Investing.com - Investing.com Nigeria

Maravai LifeSciences (MRVI) Releases Q2 2026 Earnings: Revenue Beats Estimates and Loss Narrows - Quiver Quantitative

Deutsche Bank Adjusts Maravai Lifesciences PT to $8 From $6, Maintains Buy Rating - Moomoo

Maravai LifeSciences Holdings, Inc. (MRVI) stock price, news, quote and history - Yahoo Finance Singapore

MRVI Maintains Overweight Rating by Wells Fargo -- Price Target Raised to $6.50 - GuruFocus

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap DownHere's What Happened - MarketBeat

Wells Fargo & Company Issues Positive Forecast for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat

Maravai LifeSciences posts investor presentation on mRNA, gene editing, cell and gene therapy tools platform - Bitget

Earnings call transcript: Maravai LifeSciences beats Q2 2026 estimates, shares fall - Investing.com South Africa

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Challenges with Biotech Innovation - DirectorsTalk Interviews

MRVI Looks 63.2% Overvalued on GF Value™ - GuruFocus

Is Maravai LifeSciences (MRVI) Overvalued After Q2 Earnings Miss? GF Score: 61/100 - GuruFocus

Maravai LifeSciences (MRVI) Plunges 9.92% as Shares Test Critical $5.35 Support ZoneHedge Fund Favorites - vinanet.vn

Maravai LifeSciences Q2 Earnings Call Highlights - TradingView

Maravai LifeSciences Holdings Inc (MRVI) (Q2 2026) Earnings Call - GuruFocus

Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Inv - The National Law Review

Maravai LifeSciences Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:MRVI) 2026-08-06 - Seeking Alpha

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Maravai LifeSciences Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Q2 2026 Maravai LifeSciences Holdings Inc Earnings Call Transcript - GuruFocus

MRVI: Q2 revenue up 9% to $51.4M; EBITDA guidance raised on margin expansion confidence - TradingView

MRVI: Revenue and margins rose sharply in H1 2026, with net loss narrowing and debt refinanced - TradingView

Maravai LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance

Maravai Lifesciences in focus: Can Q1 momentum hold in earnings? - Investing.com

Maravai Lifesciences in focus: Can Q1 momentum hold in earnings? By Investing.com - Investing.com Nigeria

Maravai LifeSciences (MRVI) Slips 2.5% to $6.25 as Key Support NearsInitial Balance - dars.gov.et

Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - The National Law Review

Lazard Asset Management LLC Sells 170,919 Shares of Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

Maravai LifeSciences (NASDAQ:MRVI) Downgraded by Wall Street Zen to Hold - MarketBeat

Maravai LifeSciences (MRVI) Expected to Announce Earnings on Thursday - MarketBeat

Maravai LifeSciences Holdings Inc - TradingKey

Maravai LifeSciences Holdings Inc (MRVI) Cash Flow - TradingKey

MRVI|Maravai LifeSciences Holdings Inc|Price:6.760|Chg%:-0.290 - TradingKey

TradingKey - TradingKey

MRVI|Maravai LifeSciences Holdings Inc|Price:6.690|Chg%:-0.070 - TradingKey

Maravai LifeSciences Holdings Inc (MRVI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Maravai LifeSciences Holdings Inc (MRVI) Valuation: PE, PB & Fair Value Analysis - TradingKey

Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Maravai LifeSciences Holdings Inc (MRVI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Maravai LifeSciences Holdings, Inc. Revenue Breakdown – NASDAQ:MRVI - TradingView

Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks

Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Maravai LifeSciences(MRVI) Stock Options Chain | Quotes & News - Moomoo

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - The National Law Review

Maravai LifeSciences (MRVI) Dips 2.7% as Broader Biotech Headwinds Persist; Support at $6.52 in FocusTRIN Signal - vinanet.vn

Maravai LifeSciences to announce Q2 results on August 6 - scanx.trade

Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026 - Business Wire

Price to earnings forward of Maravai Lifesciences Holdings, Inc. Class A – FWB:MAR - TradingView

Maravai LifeSciences (MRVI) Rallies 1.57% as Stock Nears Key ResistancePSAR Stop - vinanet.vn

MRVI Secures New Patent for RNA Synthesis Technology - GuruFocus

BNTX

$103.76

0.86%

INSM

$126.29

0.31%

RPRX

$63.96

0.13%

ALNY

$266.11

0.61%

ONC

$358.26

1.22%

RVMD

$210.02

0.40%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters